Insights provides context and perspective about key pharmacy trends and issues

Cost Management
CVS Health offers payors a new stop-loss program and installment payment plan to help mitigate the large one-time impact of costly gene therapies. These approaches are part of four... More
Briefing
A couple stroll together on the beach
Cost Management
In 2019, drug trend for CVS Caremark pharmacy benefit clients was a historically low, industry-leading 1.4 percent, with 41% of clients seeing negative trend. Specialty trend was in the... More
Feature
Cost Management
Our new RxZERO plan design fordiabetes eliminates member out-of-pocket costs, and enables clients to help membersimprove health outcomes without raising premiums or deductibles More
White Paper
Cost Management
Gene therapies have the potential to relieve tremendous suffering for patients with genetic disorders and together we can find ways to ensure these treatments are accessible for all those... More
White Paper
Cost Management
Payors are projected to save on per-member-per-month costs from strategic formulary removals designed to help mitigate the effect of high-cost and hyperinflationary drugs More
Briefing
Cost Management
New GAO report shows that rebates negotiated on behalf of payors may help control premiums and provides further proof of the value PBMs bring to payors and members. More
Commentary
Placeholder
Cost Management
Dynamic forces are affecting health and pharmacy care, affordability, and access. CVS Health is aligning efforts to address these challenges with... More
Video
Father and son
Cost Management
As a health care innovation company, our steadfast focus is on helping to reduce costs and improve outcomes for our pharmacy benefit management (PBM) clients and their plan members, as well... More
Feature
Read the article: Why the Time Is Right for a New Pricing Model
Cost Management
A Guaranteed Net Cost model can adapt to evolving market trends and help payors stay ahead of manufacturer strategies such as authorized generics, and changing legislative landscape. More
Briefing
Young man feeding his dog in the living room
Cost Management
Epidiolex, the latest cannabis-based drug to be approved by the FDA to treat certain seizure disorders, is a highly potent form of cannabidiol. Given the narrow indication and high cost,... More
Feature